Web of Science: 1 cites, Scopus: 14 cites, Google Scholar: cites,
Practical Update of the Guidelines Published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPs) on the Treatment of Psoriasis With Biologic Agents : Part 2 - Management of Special Populations, Patients With Comorbid Conditions, and Risk Actualización práctica de las recomendaciones del Grupo de Psoriasis de la Academia Española de Dermatología y Venereología (GPS) para el tratamiento de la psoriasis con terapia biológica. Parte 2 «Manejo de poblaciones especiales, pacientes con comorbilidad y gestión del riesgo»
Carrascosa, José Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau)
Belinchón, Isabel (Departamento de Dermatología. Hospital General Universitario de Alicante-ISABIAL- Universidad Miguel Hernández de Elche)
Salgado-Boquete, Laura (Departamento de Dermatología. Complejo Hospitalario Universitario de Pontevedra)
del Alcázar Viladomiu, Elena (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Lencina, J.J.A. (Servicio de Dermatología. Hospital Universitario Vega Baja)
Moreno-Ramírez, David (Hospital Universitario Virgen Macarena (Sevilla, Andalusia))
De la Cueva, Pablo (Servicio de Dermatología. Hospital Universitario Infanta Leonor. Universidad Complutense de Madrid)
Universitat Autònoma de Barcelona

Data: 2022
Resum: Background and objectives: Since its inception, the Psoriasis Group (GPs) of the Spanish Academy of Dermatology and Venereology (AEDV) has worked to continuously update recommendations for the treatment of psoriasis based on the best available evidence and incorporating proposals arising from and aimed at clinical practice. An updated GPs consensus document on the treatment of moderate to severe psoriasis was needed because of changes in the treatment paradigm and the approval in recent years of a large number of new biologic agents. Methodology: The consensus document was developed using the nominal group technique complemented by a scoping review. First, a designated coordinator selected a group of GPs members for the panel based on their experience and knowledge of psoriasis. The coordinator defined the objectives and key points for the document and, with the help of a documentalist, conducted a scoping review of articles in Medline, Embase, and the Cochrane Library up to January 2021. The review included systematic reviews and meta-analyses as well as clinical trials not included in those studies and high-quality real-world studies. National and international clinical practice guidelines and consensus documents on the management of moderate to severe psoriasis were also reviewed. The coordinator then drew up a set of proposed recommendations, which were discussed and modified in a nominal group meeting. After several review processes, including external review by other GPs members, the final document was drafted. Results: The present guidelines include updated recommendations on assessing the severity of psoriasis and criteria for the indication of systemic treatment. They also include general principles for the treatment of patients with moderate to severe psoriasis and define treatment goals for these patients as well as criteria for the indication and selection of initial and subsequent therapies Practical issues, such as treatment failure and maintenance of response, are also addressed.
Drets: Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, i la comunicació pública de l'obra, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. No es permet la creació d'obres derivades. Creative Commons
Llengua: Castellà
Document: Article de revisió ; recerca ; Versió publicada
Matèria: Psoriasis ; Biologic therapy ; Recommendations ; Guidelines
Publicat a: Actas Dermo-Sifiliograficas, Vol. 113 Núm. 6 (junio 2022) , p. 583-609, ISSN 1578-2190

DOI: 10.1016/j.ad.2022.01.024
PMID: 35570005


27 p, 2.6 MB

El registre apareix a les col·leccions:
Documents de recerca > Documents dels grups de recerca de la UAB > Centres i grups de recerca (producció científica) > Ciències de la salut i biociències > Institut de Recerca Sant Pau
Articles > Articles de recerca
Articles > Articles publicats

 Registre creat el 2023-07-06, darrera modificació el 2023-11-30



   Favorit i Compartir